Cited by 84Retinal Diseases and TreatmentsRetinal Imaging and AnalysisOphthalmology and Visual Health Research

The War on Diabetic Retinopathy: Where Are We Now?

Open access
Wong, Tien Y., Sabanayagam, Charumathi·2019·Asia-Pacific Journal of Ophthalmology

Abstract

Diabetic retinopathy (DR), a major cause of blindness in working-age adults, is emerging as a major public health issue worldwide, in particular in low- and middle-income countries (LMIC). Traditionally, the management of DR has been on tertiary-level treatment (eg, laser, anti-VEGF injections and surgery) in specialized settings by highly trained ophthalmologists on individual patients. To win the war on DR, a paradigm shift in strategic focus and resources must be made from such tertiary treatment toward primary and secondary prevention, which are broader, more impactful, and cost-effective for the larger population. These include improving education and awareness of risk of DR among people initially diagnosed with diabetes, promoting behavioral modifications such as physical activity and medication adherence for improving glycemic and blood pressure control, setting up systematic screening programs for DR to detect the onset or progression of the disease, and implementing cost-effective, evidence-based policies and guidelines for managing DR. Additionally, there is a need to leverage on novel technology including the application of digital big data to predict people at risk of diabetes and DR, the use of wearable devices and smart phone apps, behavioral techniques including social media for self-management of diabetes, and telemedicine-based DR screening incorporating artificial intelligence (AI) to broaden access to screening in all settings. To turn the tide on the war on DR, we must reframe DR not only as a specific condition that can be managed by ophthalmologists, but fundamentally, as a preventable condition by shifting the weight of strategies from tertiary to secondary and primary battlegrounds.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/apo.0000000000000267

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]IDF Diabetes Atlas 8th Edition. 2017; https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html.

Cited by

Sorted by citations

Authors
Wong, T. Y., & Sabanayagam, C.
Affiliations
National University of Singapore (SG)
Corresponding author
  • Wong, Tien Y.
  • Sabanayagam, Charumathi
Venue
Asia-Pacific Journal of Ophthalmology
Publisher
Elsevier BV
Published
2019-11
Volume
8
Issue
6
Pages
448-456
ISSN
2162-0989 (ISSN-L)
OpenAlex
W2992080259
Cited by
84
References
62
Citations by year
2026: 2 · 2025: 7 · 2024: 22 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 7
FWCI
9.83
Type
journal article
Language
en
Open access
Locations
  • Asia-Pacific Journal of Ophthalmology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
Keywords
diabetic retinopathy, blindness prevention, primary prevention, secondary prevention, diabetes screening, glycemic control, blood pressure control, medication adherence, physical activity, telemedicine screening, artificial intelligence, wearable devices, mobile application, digital health, low- and middle-income countries, public health policy
MeSH terms
Blindness, Diabetic Retinopathy, Humans, Mass Screening, Patient Education as Topic, Primary Health Care, Telemedicine, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review